Atlas Trials

Haemophilia A With Inhibitors

29 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Haemophilia A With Inhibitors

RecordFirmDate
A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors (NCT05053139)Novo Nordisk A/S2021-12-02
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors (NCT04083781)Novo Nordisk A/S2019-10-21
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) (NCT03741881)Novo Nordisk A/S2018-12-18
A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors (NCT03196284)Novo Nordisk A/S2017-08-10
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial (NCT02541942)Novo Nordisk A/S2015-04-03
To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives (NCT02241694)Novo Nordisk A/S2014-11-01
Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects (NCT02084810)Novo Nordisk A/S2014-03-01
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia (NCT01988532)Novo Nordisk A/S2013-10-01
A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors (NCT01949792)Novo Nordisk A/S2013-09-01
Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries (NCT01503567)Novo Nordisk A/S2012-01-01
Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors (NCT01392547)Novo Nordisk A/S2011-07-01
Survey Evaluating the Psychosocial Effects of Living With Haemophilia (NCT01322620)Novo Nordisk A/S2011-06-03
A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors (NCT01830712)Novo Nordisk A/S2011-04-01
PROPACT: Retrospective Prophylaxis Patient Case Collection (NCT00882778)Novo Nordisk A/S2009-04-01
Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors (NCT00703911)Novo Nordisk A/S2008-03-01
Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects (NCT01561417)Novo Nordisk A/S2006-04-01
Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography (NCT01561924)Novo Nordisk A/S2005-11-01
Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia (NCT00108758)Novo Nordisk A/S2004-03-01
High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors (NCT00571584)Novo Nordisk A/S2002-11-01
Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers (NCT01563471)Novo Nordisk A/S2001-10-01
Trial of NovoSeven® in Haemophilia - Joint Bleeds (NCT00108797)Novo Nordisk A/S2001-09-01
Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice (NCT01579955)Novo Nordisk A/S1999-03-10
Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors (NCT01586936)Novo Nordisk A/S1999-03-10
Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery (NCT01579968)Novo Nordisk A/S1999-03-10
Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery (NCT01561391)Novo Nordisk A/S1998-04-01

Track Haemophilia A With Inhibitors automatically

Every clearance here is in the API, with alerts when new ones post.